本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fulcrum Therapeutics

3.79
-0.0100-0.26%
盤後3.790.00000.00%19:30 EDT
成交量:70.65萬
成交額:267.76萬
市值:2.89億
市盈率:-3.13
高:3.82
開:3.82
低:3.78
收:3.80
52周最高:15.74
52周最低:2.83
股本:7,629.73萬
流通股本:6,349.06萬
量比:0.63
換手率:1.11%
股息:- -
股息率:- -
每股收益(TTM):-1.2104
每股收益(LYR):-1.1819
淨資產收益率:-32.38%
總資產收益率:-19.59%
市淨率:0.93
市盈率(LYR):-3.21

資料載入中...

2023/10/03

重要事件披露

Form 8-K - Current report
2023/08/22

重要事件披露

Form 8-K - Current report
2023/08/03

重要事件披露

Form 8-K - Current report
2023/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/11

重要事件披露

Form 8-K - Current report
2023/06/26

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/26

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/24

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/10

重要事件披露

Form 8-K - Current report
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/15

重要事件披露

Form 8-K - Current report
2023/04/05

重要事件披露

8-K - Current report
2023/03/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/09

重要事件披露

8-K - Current report
2023/03/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/06

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals